Time course of enzyme induction in humans: Effect of pentobarbital on nortriptyline metabolism

被引:43
作者
von Bahr, C [1 ]
Steiner, E
Koike, Y
Gabrielsson, J
机构
[1] Sodersjukhuset Hosp, Dept Med, Div Clin Pharmacol, S-11883 Stockholm, Sweden
[2] Huddinge Hosp, Karolinska Inst, Dept Med Lab Sci & Technol, Div Clin Pharmacol, S-14186 Huddinge, Sweden
关键词
D O I
10.1016/S0009-9236(98)90018-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To study the effect of induction we gave six male volunteers 10 mg nortriptyline three times a day for 4 weeks and 0.2 gm pentobarbital on days 8 to 21, Plasma and urinary levels of nortriptyline and metabolites were measured. The rate and extent of induction of the enzyme(s) were estimated by a model with use of nortriptyline concentrations, There was a marked decrease of nortriptyline levels after 2 days of pentobarbital treatment. Total clearance of nortriptyline increased more than twofold (range, 1.6-fold to 4.1-fold). Apparent metabolic clearance by 10-hydroxylation increased markedly. The decrease in nortriptyline levels was more rapid than the increase after pentobarbital cessation, fitting with the theory of the model, The induction of nortriptyline metabolism is probably mainly the result of an increase in a non-CYP 2D6 P450 isozyme, possibly CYP 3A4 or a CYP 2C form, More knowledge of induction characteristics of drugs should lead to better predictions of decreased effects and appearance of adverse effects. The kinetic model used for analysis of our data could then be useful.
引用
收藏
页码:18 / 26
页数:9
相关论文
共 42 条
[1]   KINETIC-MODELS OF INDUCTION .1. PERSISTENCE OF THE INDUCING SUBSTANCE [J].
ABRAMSON, FP .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (03) :223-228
[2]   STEADY-STATE PLASMA LEVELS OF NORTRIPTYLINE INTWINS - INFLUENCE OF GENETIC FACTORS AND DRUG THERAPY [J].
ALEXANDERSON, B ;
EVANS, DAP ;
SJOQVIST, F .
BMJ-BRITISH MEDICAL JOURNAL, 1969, 4 (5686) :764-+
[3]   URINARY-EXCRETION OF NORTRIPTYLINE AND 5 OF ITS METABOLITES IN MAN AFTER SINGLE AND MULTIPLE ORAL DOSES [J].
ALEXANDERSON, B ;
BORGA, O .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1973, 5 (03) :174-180
[4]  
ALVAN G, 1977, CLIN PHARMACOL THER, V22, P316
[5]  
BALDEO W C, 1980, European Journal of Drug Metabolism and Pharmacokinetics, V5, P75
[6]   PHARMACOKINETICS - TIME-DEPENDENT CHANGES - AUTOINDUCTION OF CARBAMAZEPINE EPOXIDATION [J].
BERTILSSON, L ;
TOMSON, T ;
TYBRING, G .
JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 26 (06) :459-462
[7]   STEREOSPECIFIC HYDROXYLATION OF NORTRIPTYLINE IN MAN IN RELATION TO INTERINDIVIDUAL DIFFERENCES IN ITS STEADY-STATE PLASMA LEVEL [J].
BERTILSSON, L ;
ALEXANDERSON, B .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1972, 4 (04) :201-+
[8]   DISPOSITION OF SINGLE ORAL DOSES OF E-10-HYDROXYNORTRIPTYLINE IN HEALTHY-SUBJECTS, WITH SOME OBSERVATIONS ON PHARMACODYNAMIC EFFECTS [J].
BERTILSSON, L ;
NORDIN, C ;
OTANI, K ;
RESUL, B ;
SCHEININ, M ;
SIWERS, B ;
SJOQVIST, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (03) :261-267
[9]  
BORGA O, 1973, 5 INT PHARM C BAS, P56
[10]  
BRECKENRIDGE A, 1973, CLIN PHARMACOL THER, V14, P514